Healthcare Costs and Resource Utilization in Patients with Multiple Sclerosis Relapses Treated with H.P. Acthar Gel®

Overview of attention for article published in Advances in Therapy, June 2016

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
One of the highest-scoring outputs from this source (#3 of 2,399)
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (98th percentile)

Mentioned by

news: 70 news outlets
twitter: 4 X users

patent: 1 patent

Citations

dimensions_citation: 19 Dimensions

Readers on

mendeley: 28 Mendeley

Summary News X Patents Dimensions citations

So far, Altmetric has seen 78 news stories from 70 outlets.

Mallinckrodt plc Presents Multiple Sclerosis (MS) Relapse Data at 7th Joint ECTRIMS-ACTRIMS Meeting (MSParis2017)

BioTech Gate, 26 Oct 2017

STAINES-UPON-THAMES, United Kingdom, Oct. 26, 2017 /PRNewswire/ -- Mallinckrodt plc (NYSE: MNK), a leading global specialty…

Mallinckrodt plc Presents Multiple Sclerosis (MS) Relapse Data at 7th Joint ECTRIMS-ACTRIMS Meeting (MSParis2017)

KTRE, 26 Oct 2017

Information contained on this page is provided by an independent third-party content provider.

Mallinckrodt plc Presents Multiple Sclerosis (MS) Relapse Data at 7th Joint ECTRIMS-ACTRIMS Meeting (MSParis2017)

2 News, 26 Oct 2017

Information contained on this page is provided by an independent third-party content provider.

Mallinckrodt plc Presents Multiple Sclerosis (MS) Relapse Data at 7th Joint ECTRIMS-ACTRIMS Meeting (MSParis2017)

Ticker Tech, 26 Oct 2017

STAINES-UPON-THAMES, United Kingdom, Oct. 26, 2017 /PRNewswire/ -- Mallinckrodt plc (NYSE: MNK), a leading global specialty…

Mallinckrodt plc Presents Multiple Sclerosis (MS) Relapse Data at 7th Joint ECTRIMS-ACTRIMS Meeting (MSParis2017)

Benzinga, 26 Oct 2017

-- Retrospective Analyses Compared H.P. Acthar® Gel (Repository Corticotropin Injection) with Non-Corticosteroid Treatments on…

Mallinckrodt plc Presents Multiple Sclerosis (MS) Relapse Data at 7th Joint ECTRIMS-ACTRIMS Meeting (MSParis2017)

Ariva, 26 Oct 2017

PR Newswire STAINES-UPON-THAMES, United Kingdom, Oct. 26, 2017 STAINES-UPON-THAMES, United Kingdom, Oct.

Mallinckrodt plc Presents Multiple Sclerosis (MS) Relapse Data at 7th Joint ECTRIMS-ACTRIMS Meeting (MSParis2017)

Minyanville: Finance , 26 Oct 2017

Presents Multiple Sclerosis (MS) Relapse Data at 7th Joint ECTRIMS-ACTRIMS Meeting (MSParis2017) STAINES-UPON-THAMES, United…

Mallinckrodt plc Presents Multiple Sclerosis (MS) Relapse Data at 7th Joint ECTRIMS-ACTRIMS Meeting (MSParis2017)

NASDAQ, 26 Oct 2017

-- Retrospective Analyses Compared H.P. Acthar® Gel (Repository Corticotropin Injection) with Non-Corticosteroid Treatments on…

Health care resource use and costs of H.P. Acthar® gel for multiple sclerosis relapse

The Medical News, 06 Jul 2016

Mallinckrodt plc, a leading global specialty biopharmaceutical company, today announced new retrospective health economic data…

Health Care Resource Use and Costs of H.P. Acthar® Gel (Repository Corticotropin Injection) for Multiple Sclerosis Relapse

BioMed Reports, 06 Jul 2016

"Managing relapses is a central concern for the overall management of MS, yet there are few studies that compare these three…

Health Care Resource Use and Costs of H.P. Acthar® Gel (Repository Corticotropin Injection) for Multiple Sclerosis Relapse

WLOX, 05 Jul 2016

SOURCE Mallinckrodt - Retrospective Health Economic Data Published in Advances in Therapy Show Acthar May Be an Important…

Health Care Resource Use and Costs of H.P. Acthar® Gel (Repository Corticotropin Injection) for Multiple Sclerosis Relapse

ABC 7 News KSWO, 05 Jul 2016

SOURCE Mallinckrodt - Retrospective Health Economic Data Published in Advances in Therapy Show Acthar May Be an Important…

Health Care Resource Use and Costs of H.P. Acthar® Gel (Repository Corticotropin Injection) for Multiple Sclerosis Relapse

News Channel 6, 05 Jul 2016

SOURCE Mallinckrodt - Retrospective Health Economic Data Published in Advances in Therapy Show Acthar May Be an Important…

Health Care Resource Use and Costs of H.P. Acthar® Gel (Repository Corticotropin Injection) for Multiple Sclerosis Relapse

WLTZ, 05 Jul 2016

SOURCE Mallinckrodt - Retrospective Health Economic Data Published in Advances in Therapy Show Acthar May Be an Important…

Health Care Resource Use and Costs of H.P. Acthar® Gel (Repository Corticotropin Injection) for Multiple Sclerosis Relapse

WDAM - TV, 05 Jul 2016

SOURCE Mallinckrodt - Retrospective Health Economic Data Published in Advances in Therapy Show Acthar May Be an Important…

Health Care Resource Use and Costs of H.P. Acthar® Gel (Repository Corticotropin Injection) for Multiple Sclerosis Relapse

KHQ, 05 Jul 2016

SOURCE Mallinckrodt - Retrospective Health Economic Data Published in Advances in Therapy Show Acthar May Be an Important…

Health Care Resource Use and Costs of H.P. Acthar® Gel (Repository Corticotropin Injection) for Multiple Sclerosis Relapse

14 News, 05 Jul 2016

SOURCE Mallinckrodt - Retrospective Health Economic Data Published in Advances in Therapy Show Acthar May Be an Important…

Health Care Resource Use and Costs of H.P. Acthar® Gel (Repository Corticotropin Injection) for Multiple Sclerosis Relapse

NBC Right Now KNDU 25, 05 Jul 2016

SOURCE Mallinckrodt - Retrospective Health Economic Data Published in Advances in Therapy Show Acthar May Be an Important…

Health Care Resource Use and Costs of H.P. Acthar® Gel (Repository Corticotropin Injection) for Multiple Sclerosis Relapse

KSLA News 12, 05 Jul 2016

SOURCE Mallinckrodt - Retrospective Health Economic Data Published in Advances in Therapy Show Acthar May Be an Important…

Health Care Resource Use and Costs of H.P. Acthar® Gel (Repository Corticotropin Injection) for Multiple Sclerosis Relapse

WTVM, 05 Jul 2016

SOURCE Mallinckrodt - Retrospective Health Economic Data Published in Advances in Therapy Show Acthar May Be an Important…

Health Care Resource Use and Costs of H.P. Acthar® Gel (Repository Corticotropin Injection) for Multiple Sclerosis Relapse

WTOC, 05 Jul 2016

SOURCE Mallinckrodt - Retrospective Health Economic Data Published in Advances in Therapy Show Acthar May Be an Important…

Health Care Resource Use and Costs of H.P. Acthar® Gel (Repository Corticotropin Injection) for Multiple Sclerosis Relapse

Cleveland 19, 05 Jul 2016

SOURCE Mallinckrodt - Retrospective Health Economic Data Published in Advances in Therapy Show Acthar May Be an Important…

Health Care Resource Use and Costs of H.P. Acthar® Gel (Repository Corticotropin Injection) for Multiple Sclerosis Relapse

NewsWest9, 05 Jul 2016

SOURCE Mallinckrodt - Retrospective Health Economic Data Published in Advances in Therapy Show Acthar May Be an Important…

Health Care Resource Use and Costs of H.P. Acthar® Gel (Repository Corticotropin Injection) for Multiple Sclerosis Relapse

NewsOn6, 05 Jul 2016

SOURCE Mallinckrodt - Retrospective Health Economic Data Published in Advances in Therapy Show Acthar May Be an Important…

Health Care Resource Use and Costs of H.P. Acthar® Gel (Repository Corticotropin Injection) for Multiple Sclerosis Relapse

NBC12, 05 Jul 2016

SOURCE Mallinckrodt - Retrospective Health Economic Data Published in Advances in Therapy Show Acthar May Be an Important…

Health Care Resource Use and Costs of H.P. Acthar® Gel (Repository Corticotropin Injection) for Multiple Sclerosis Relapse

KAIT-TV, 05 Jul 2016

SOURCE Mallinckrodt - Retrospective Health Economic Data Published in Advances in Therapy Show Acthar May Be an Important…

Health Care Resource Use and Costs of H.P. Acthar® Gel (Repository Corticotropin Injection) for Multiple Sclerosis Relapse

WMBF News, 05 Jul 2016

SOURCE Mallinckrodt - Retrospective Health Economic Data Published in Advances in Therapy Show Acthar May Be an Important…

Health Care Resource Use and Costs of H.P. Acthar® Gel (Repository Corticotropin Injection) for Multiple Sclerosis Relapse

Hawaii News Now, 05 Jul 2016

SOURCE Mallinckrodt - Retrospective Health Economic Data Published in Advances in Therapy Show Acthar May Be an Important…

Health Care Resource Use and Costs of H.P. Acthar® Gel (Repository Corticotropin Injection) for Multiple Sclerosis Relapse

KUSI News, 05 Jul 2016

SOURCE Mallinckrodt - Retrospective Health Economic Data Published in Advances in Therapy Show Acthar May Be an Important…

Health Care Resource Use and Costs of H.P. Acthar® Gel (Repository Corticotropin Injection) for Multiple Sclerosis Relapse

Mississippi News Now , 05 Jul 2016

SOURCE Mallinckrodt - Retrospective Health Economic Data Published in Advances in Therapy Show Acthar May Be an Important…

Health Care Resource Use and Costs of H.P. Acthar® Gel (Repository Corticotropin Injection) for Multiple Sclerosis Relapse

Fox Wilmington, 05 Jul 2016

SOURCE Mallinckrodt - Retrospective Health Economic Data Published in Advances in Therapy Show Acthar May Be an Important…

Health Care Resource Use and Costs of H.P. Acthar® Gel (Repository Corticotropin Injection) for Multiple Sclerosis Relapse

CW: Richmond, 05 Jul 2016

SOURCE Mallinckrodt - Retrospective Health Economic Data Published in Advances in Therapy Show Acthar May Be an Important…

Health Care Resource Use and Costs of H.P. Acthar® Gel (Repository Corticotropin Injection) for Multiple Sclerosis Relapse

KCBD, 05 Jul 2016

SOURCE Mallinckrodt - Retrospective Health Economic Data Published in Advances in Therapy Show Acthar May Be an Important…

Health Care Resource Use and Costs of H.P. Acthar® Gel (Repository Corticotropin Injection) for Multiple Sclerosis Relapse

WBOC 16, 05 Jul 2016

SOURCE Mallinckrodt - Retrospective Health Economic Data Published in Advances in Therapy Show Acthar May Be an Important…

Health Care Resource Use and Costs of H.P. Acthar® Gel (Repository Corticotropin Injection) for Multiple Sclerosis Relapse

12 News KBMT, 05 Jul 2016

SOURCE Mallinckrodt - Retrospective Health Economic Data Published in Advances in Therapy Show Acthar May Be an Important…

Health Care Resource Use and Costs of H.P. Acthar® Gel (Repository Corticotropin Injection) for Multiple Sclerosis Relapse

Fox 14 News, 05 Jul 2016

SOURCE Mallinckrodt - Retrospective Health Economic Data Published in Advances in Therapy Show Acthar May Be an Important…

Health Care Resource Use and Costs of H.P. Acthar® Gel (Repository Corticotropin Injection) for Multiple Sclerosis Relapse

KiiiTV 3 , 05 Jul 2016

SOURCE Mallinckrodt - Retrospective Health Economic Data Published in Advances in Therapy Show Acthar May Be an Important…

Health Care Resource Use and Costs of H.P. Acthar® Gel (Repository Corticotropin Injection) for Multiple Sclerosis Relapse

KLTV, 05 Jul 2016

SOURCE Mallinckrodt - Retrospective Health Economic Data Published in Advances in Therapy Show Acthar May Be an Important…

Health Care Resource Use and Costs of H.P. Acthar® Gel (Repository Corticotropin Injection) for Multiple Sclerosis Relapse

WDRB, 05 Jul 2016

SOURCE Mallinckrodt - Retrospective Health Economic Data Published in Advances in Therapy Show Acthar May Be an Important…

Health Care Resource Use and Costs of H.P. Acthar® Gel (Repository Corticotropin Injection) for Multiple Sclerosis Relapse

KCENG12, 05 Jul 2016

SOURCE Mallinckrodt - Retrospective Health Economic Data Published in Advances in Therapy Show Acthar May Be an Important…

Health Care Resource Use and Costs of H.P. Acthar® Gel (Repository Corticotropin Injection) for Multiple Sclerosis Relapse

WISTV, 05 Jul 2016

SOURCE Mallinckrodt - Retrospective Health Economic Data Published in Advances in Therapy Show Acthar May Be an Important…

Health Care Resource Use and Costs of H.P. Acthar® Gel (Repository Corticotropin Injection) for Multiple Sclerosis Relapse

WFMJ, 05 Jul 2016

SOURCE Mallinckrodt - Retrospective Health Economic Data Published in Advances in Therapy Show Acthar May Be an Important…

Health Care Resource Use and Costs of H.P. Acthar® Gel (Repository Corticotropin Injection) for Multiple Sclerosis Relapse

KX News, 05 Jul 2016

SOURCE Mallinckrodt - Retrospective Health Economic Data Published in Advances in Therapy Show Acthar May Be an Important…

Health Care Resource Use and Costs of H.P. Acthar® Gel (Repository Corticotropin Injection) for Multiple Sclerosis Relapse

WFLX Fox 29, 05 Jul 2016

SOURCE Mallinckrodt - Retrospective Health Economic Data Published in Advances in Therapy Show Acthar May Be an Important…

Health Care Resource Use and Costs of H.P. Acthar® Gel (Repository Corticotropin Injection) for Multiple Sclerosis Relapse

48 WAFF, 05 Jul 2016

SOURCE Mallinckrodt - Retrospective Health Economic Data Published in Advances in Therapy Show Acthar May Be an Important…

Health Care Resource Use and Costs of H.P. Acthar® Gel (Repository Corticotropin Injection) for Multiple Sclerosis Relapse

South Carolina News Now, 05 Jul 2016

SOURCE Mallinckrodt - Retrospective Health Economic Data Published in Advances in Therapy Show Acthar May Be an Important…

Health Care Resource Use and Costs of H.P. Acthar® Gel (Repository Corticotropin Injection) for Multiple Sclerosis Relapse

WSFA , 05 Jul 2016

SOURCE Mallinckrodt - Retrospective Health Economic Data Published in Advances in Therapy Show Acthar May Be an Important…

Health Care Resource Use and Costs of H.P. Acthar® Gel (Repository Corticotropin Injection) for Multiple Sclerosis Relapse

WTOL, 05 Jul 2016

SOURCE Mallinckrodt - Retrospective Health Economic Data Published in Advances in Therapy Show Acthar May Be an Important…

Health Care Resource Use and Costs of H.P. Acthar® Gel (Repository Corticotropin Injection) for Multiple Sclerosis Relapse

ABC 6 News WLNE, 05 Jul 2016

SOURCE Mallinckrodt - Retrospective Health Economic Data Published in Advances in Therapy Show Acthar May Be an Important…

Health Care Resource Use and Costs of H.P. Acthar® Gel (Repository Corticotropin Injection) for Multiple Sclerosis Relapse

WRCB- TV, 05 Jul 2016

SOURCE Mallinckrodt - Retrospective Health Economic Data Published in Advances in Therapy Show Acthar May Be an Important…

Health Care Resource Use and Costs of H.P. Acthar® Gel (Repository Corticotropin Injection) for Multiple Sclerosis Relapse

ABC 40, 05 Jul 2016

SOURCE Mallinckrodt - Retrospective Health Economic Data Published in Advances in Therapy Show Acthar May Be an Important…

Health Care Resource Use and Costs of H.P. Acthar® Gel (Repository Corticotropin Injection) for Multiple Sclerosis Relapse

WAND 17, 05 Jul 2016

SOURCE Mallinckrodt - Retrospective Health Economic Data Published in Advances in Therapy Show Acthar May Be an Important…

Health Care Resource Use and Costs of H.P. Acthar® Gel (Repository Corticotropin Injection) for Multiple Sclerosis Relapse

News 9, 05 Jul 2016

SOURCE Mallinckrodt - Retrospective Health Economic Data Published in Advances in Therapy Show Acthar May Be an Important…

Health Care Resource Use and Costs of H.P. Acthar® Gel (Repository Corticotropin Injection) for Multiple Sclerosis Relapse

News Channel, 05 Jul 2016

SOURCE Mallinckrodt - Retrospective Health Economic Data Published in Advances in Therapy Show Acthar May Be an Important…

Health Care Resource Use and Costs of H.P. Acthar® Gel (Repository Corticotropin Injection) for Multiple Sclerosis Relapse

KLKN-TV Eyewitness News, 05 Jul 2016

SOURCE Mallinckrodt - Retrospective Health Economic Data Published in Advances in Therapy Show Acthar May Be an Important…

Health Care Resource Use and Costs of H.P. Acthar® Gel (Repository Corticotropin Injection) for Multiple Sclerosis Relapse

Kuam, 05 Jul 2016

SOURCE Mallinckrodt - Retrospective Health Economic Data Published in Advances in Therapy Show Acthar May Be an Important…

Health Care Resource Use and Costs of H.P. Acthar® Gel (Repository Corticotropin Injection) for Multiple Sclerosis Relapse

WMC Action News 5, 05 Jul 2016

SOURCE Mallinckrodt - Retrospective Health Economic Data Published in Advances in Therapy Show Acthar May Be an Important…

Health Care Resource Use and Costs of H.P. Acthar® Gel (Repository Corticotropin Injection) for Multiple Sclerosis Relapse

CBS8, 05 Jul 2016

SOURCE Mallinckrodt - Retrospective Health Economic Data Published in Advances in Therapy Show Acthar May Be an Important…

Health Care Resource Use and Costs of H.P. Acthar® Gel (Repository Corticotropin Injection) for Multiple Sclerosis Relapse

KTEN, 05 Jul 2016

SOURCE Mallinckrodt - Retrospective Health Economic Data Published in Advances in Therapy Show Acthar May Be an Important…

Health Care Resource Use and Costs of H.P. Acthar® Gel (Repository Corticotropin Injection) for Multiple Sclerosis Relapse

KFVE The Home Team, 05 Jul 2016

SOURCE Mallinckrodt - Retrospective Health Economic Data Published in Advances in Therapy Show Acthar May Be an Important…

Health Care Resource Use and Costs of H.P. Acthar® Gel (Repository Corticotropin Injection) for Multiple Sclerosis Relapse

KPLC 7 News, 05 Jul 2016

SOURCE Mallinckrodt - Retrospective Health Economic Data Published in Advances in Therapy Show Acthar May Be an Important…

Health Care Resource Use and Costs of H.P. Acthar® Gel (Repository Corticotropin Injection) for Multiple Sclerosis Relapse

Erie News Now, 05 Jul 2016

SOURCE Mallinckrodt - Retrospective Health Economic Data Published in Advances in Therapy Show Acthar May Be an Important…

Health Care Resource Use and Costs of H.P. Acthar® Gel (Repository Corticotropin Injection) for Multiple Sclerosis Relapse

Wave 3 News, 05 Jul 2016

SOURCE Mallinckrodt - Retrospective Health Economic Data Published in Advances in Therapy Show Acthar May Be an Important…

Health Care Resource Use and Costs of H.P. Acthar® Gel (Repository Corticotropin Injection) for Multiple Sclerosis Relapse

2 News, 05 Jul 2016

SOURCE Mallinckrodt - Retrospective Health Economic Data Published in Advances in Therapy Show Acthar May Be an Important…

Health Care Resource Use and Costs of H.P. Acthar® Gel (Repository Corticotropin Injection) for Multiple Sclerosis Relapse

KTRE, 05 Jul 2016

SOURCE Mallinckrodt - Retrospective Health Economic Data Published in Advances in Therapy Show Acthar May Be an Important…

Health Care Resource Use and Costs of H.P. Acthar® Gel (Repository Corticotropin Injection) for Multiple Sclerosis Relapse

WALB, 05 Jul 2016

SOURCE Mallinckrodt - Retrospective Health Economic Data Published in Advances in Therapy Show Acthar May Be an Important…

Health Care Resource Use and Costs of H.P. Acthar® Gel (Repository Corticotropin Injection) for Multiple Sclerosis Relapse

Noodls, 05 Jul 2016

Mallinckrodt plc (via noodls) / Health Care Resource Use and Costs of H.P. Acthar® Gel (Repository Corticotropin Injection) for…

Health Care Resource Use and Costs of H.P. Acthar® Gel (Repository Corticotropin Injection) for Multiple Sclerosis Relapse

BioTech Gate, 05 Jul 2016

/PRNewswire/ -- Mallinckrodt plc (NYSE: MNK), a leading global specialty biopharmaceutical company, today announced new…

Health Care Resource Use and Costs of H.P. Acthar® Gel (Repository Corticotropin Injection) for Multiple Sclerosis Relapse

Ariva, 05 Jul 2016

/PRNewswire/ -- Mallinckrodt plc (NYSE: MNK), a leading global specialty biopharmaceutical company, today announced new…

Health Care Resource Use and Costs of H.P. Acthar® Gel (Repository Corticotropin Injection) for Multiple Sclerosis Relapse

Benzinga, 05 Jul 2016

- Retrospective Health Economic Data Published in Advances in Therapy Show Acthar May Be an Important Treatment Option for…

Health Care Resource Use and Costs of H.P. Acthar® Gel (Repository Corticotropin Injection) for Multiple Sclerosis Relapse

Ticker Tech, 05 Jul 2016

/PRNewswire/ -- Mallinckrodt plc (NYSE: MNK), a leading global specialty biopharmaceutical company, today announced new…

News story from Bloomberg on Tuesday 05 July 2016

Bloomberg, 05 Jul 2016

Health Care Resource Use and Costs of H.P. Acthar® Gel (Repository Corticotropin Injection) for Multiple Sclerosis Relapse

Yahoo! Finance Singapore, 05 Jul 2016

/PRNewswire/ -- Mallinckrodt plc ( MNK ), a leading global specialty biopharmaceutical company, today announced new…

Health Care Resource Use and Costs of H.P. Acthar® Gel (Repository Corticotropin Injection) for Multiple Sclerosis Relapse

PR Newswire, 05 Jul 2016

- Retrospective Health Economic Data Published in Advances in Therapy Show Acthar May Be an Important Treatment Option for…

Health Care Resource Use and Costs of H.P. Acthar® Gel (Repository Corticotropin Injection) for Multiple Sclerosis Relapse

Stock Nod: Quotes, 05 Jul 2016

CHESTERFIELD, United Kingdom "This study adds to the body of data discussing Acthar," said Steve Romano "Managing relapses is a…

Health Care Resource Use and Costs of H.P. Acthar® Gel (Repository Corticotropin Injection) for Multiple Sclerosis Relapse

Yahoo! Finance USA, 05 Jul 2016

- Retrospective Health Economic Data Published in Advances in Therapy Show Acthar May Be an Important Treatment Option for…

Health Care Resource Use and Costs of H.P. Acthar® Gel (Repository Corticotropin Injection) for Multiple Sclerosis Relapse

Minyanville: Finance , 05 Jul 2016

CHESTERFIELD, United Kingdom, July 5, 2016 /PRNewswire/ -- Mallinckrodt plc ( NYSE: MNK ), a leading global specialty…

Health Care Resource Use and Costs of H.P. Acthar® Gel (Repository Corticotropin Injection) for Multiple Sclerosis Relapse

NASDAQ, 05 Jul 2016

/PRNewswire/ -- Mallinckrodt plc (NYSE:MNK), a leading global specialty biopharmaceutical company, today announced new…